Mechanisms underlying reductant-induced reactive oxygen species formation by anticancer copper(II) compounds.
about
Copper(ii) thiosemicarbazone complexes induce marked ROS accumulation and promote nrf2-mediated antioxidant response in highly resistant breast cancer cells.Mechanistic characterization of a copper containing thiosemicarbazone with potent antitumor activity.Distinct mechanisms of cell-kill by triapine and its terminally dimethylated derivative Dp44mT due to a loss or gain of activity of their copper(II) complexes.Potent Half-Sandwich Iridium(III) Anticancer Complexes Containing C(∧)N-Chelated and Pyridine Ligands.Strong effect of copper(II) coordination on antiproliferative activity of thiosemicarbazone-piperazine and thiosemicarbazone-morpholine hybrids.Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axisStructurally related hydrazone-based metal complexes with different antitumor activities variably induce apoptotic cell death.Synthesis, X-ray structure and in vitro cytotoxicity studies of Cu(I/II) complexes of thiosemicarbazone: special emphasis on their interactions with DNA.High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium.Synthesis, crystal structure, spectroscopic properties and potential biological activities of salicylate‒neocuproine ternary copper(II) complexes.A ratiometric fluorescent sensor for the mitochondrial copper pool.Destruxins: fungal-derived cyclohexadepsipeptides with multifaceted anticancer and antiangiogenic activities.
P2860
Q31172464-82710632-DF96-4566-8CF2-D725518145D2Q33728282-55D26D4D-CF6B-4FA8-B62A-82AD2F8826E6Q34178561-B80227B9-D50A-4F70-9450-F6C62E47E981Q34331245-CF10B1CD-46DE-44CE-8F09-87CA749D0E2CQ35610388-8B17DC2A-497B-41B0-9A70-85CFC0387DA4Q37420167-3458ECF2-3C85-4C25-B7E5-27E21144DD14Q38710830-405DEE94-E2CF-4863-963A-6498D9D21467Q38904045-6A153906-DD31-4AB4-9852-5D4E63263320Q46390552-71484825-9F8E-4948-8061-9FD0D13A0586Q46780343-BE8C04F3-50A4-45B9-8656-621D2BD0983BQ50197759-0CC6A7AA-FC7A-4F08-91D5-2B3217B13326Q50926583-BA40FC2A-3A3C-476F-8C97-1EB1D32C20CB
P2860
Mechanisms underlying reductant-induced reactive oxygen species formation by anticancer copper(II) compounds.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Mechanisms underlying reductan ...... formation by anticancer copper
@nl
Mechanisms underlying reductan ...... ticancer copper(II) compounds.
@en
type
label
Mechanisms underlying reductan ...... formation by anticancer copper
@nl
Mechanisms underlying reductan ...... ticancer copper(II) compounds.
@en
prefLabel
Mechanisms underlying reductan ...... formation by anticancer copper
@nl
Mechanisms underlying reductan ...... ticancer copper(II) compounds.
@en
P2093
P2860
P50
P1476
Mechanisms underlying reductan ...... ticancer copper(II) compounds.
@en
P2093
Lars Gille
Loredana Cappellacci
Robert Trondl
Walter Miklos
P2860
P2888
P304
P356
10.1007/S00775-011-0864-X
P577
2011-12-22T00:00:00Z